The University of Texas Southwestern
Southwestern Medical Center at Dallas
2201 Inwood Rd
Dallas, TX 75390-8562
Direct phone: (214) 645-HOPE (4673)
Toll-free: (866) 460-HOPE (4673)
Total transplants by cell source
- Marrow: 5
- PBSC: 54
- Cord Blood: 0
- Autologous (PBSC or Marrow): 145
About the center
The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwesterns Harold C. Simmons Comprehensive Cancer Center is one of the nations leading programs for hematologic malignancies. With a focus on excellence and compassion, our physicians and staff manage patients at all stages of their care. The program has an excellent track record in the delivery of state-of-the-art transplants. In addition, the program features an active translational research component that aims to improve transplant results by applying recent advances in immunobiology to the clinic.
This center has been performing allogeneic transplants since 1999 and has been an NMDP/Be The Match transplant center since December 2001.
Adult - Larry Anderson, Farrukh l Awan, Stephen Chung, Robert Collins, Ankit Kansagra , Yazan Madanat, Prati Patel, Praveen Ramakrishnan, Syed Rizvi, Madhuri Vusirikala
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
As part of the only National Cancer Institute-designated Comprehensive Cancer Center in North Texas, The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern Medical Center is able to offer referring physicians and patients a range of services unsurpassed in the region, including:
Diagnosis and treatment of all hematologic malignancies
Stem cell transplantation - autologous, allogeneic related and unrelated, cord blood, haploidentical)
Specialized center for acute myeloid leukemia and myelodysplastic syndrome, plasma cell neoplasms (multiple myeloma, Waldenstroms macroglobulinemia, and amyloidosis), chronic lymphocytic leukemia, and acute lymphoblastic leukemia
Familial malignancies clinic
Cutaneous T-cell lymphoma clinic
CNS lymphoma clinic
Chronic GVHD (graft-versus-host disease) clinic
Comprehensive second opinion service
Nationally renowned hematopathology (microscopy, flow cytometry, cytogenetics, molecular diagnostics)
In-depth genetic and functional screening of patients with relapsed/refractory malignancies, allowing for individualized molecular-targeted therapy
Extensive Clinical Trials
Blood and Marrow Transplantation patients at UT Southwestern and Simmons Cancer Center have access to the latest advances and treatments through our clinical trials program, which typically includes 30 or more phase I-III clinical trials at any time.
CAR T-cell Therapy
UTSW has a very active program in CAR T-cells, for standard-of-care indications including certain types of diffuse large B-cell lymphoma and acute lymphoblastic leukemia as well as experimental indications, including multiple myeloma and several other B-cell malignancy subtypes.
Multidisciplinary Treatment Teams
Highly integrated and coordinated multidisciplinary teams provide optimal, state-of-the-art care. Teams are composed of physicians who specialize solely in hematologic malignancies, oncology-certified nurses and transitional coordinators, advance
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 81 patients.
The actual 1-year survival of these patients is 75.3%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.6% and 83.6%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2017 to December 31st, 2018 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2017 to December 31st, 2018 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
If you have transplant-related questions, please call the transplant center's direct phone number.
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)